Viewing Study NCT02676518



Ignite Creation Date: 2024-05-06 @ 8:09 AM
Last Modification Date: 2024-10-26 @ 11:56 AM
Study NCT ID: NCT02676518
Status: UNKNOWN
Last Update Posted: 2016-02-08
First Post: 2015-08-19

Brief Title: AMH Glucose Intolerance and Metabolic Syndrome in PCOS
Sponsor: Chulalongkorn University
Organization: Chulalongkorn University

Study Overview

Official Title: Anti-Müllerian Hormone and Its Association With Glucose Intolerance and Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Status: UNKNOWN
Status Verified Date: 2016-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Association between serum anti-Mullerian hormone AMH level and prevalence of glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome PCOS
Detailed Description: To study the association between serum anti-Mullerian hormone AMH level and glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome PCOS
Glucose intolerance is detected by 2-hours 75 gram oral glucose tolerance test OGTT
Metabolic syndrome is diagnosed by using the Harmonized criteria the presence of any 3 of 5 following risk factors constitutes a diagnosis of metabolic syndrome

1 Elevated waist circumference 80 cm in Asian women
2 Elevated triglycerides 150 mgdL
3 Reduced HDL-cholesterol 50 mgdL
4 Elevated blood pressure systolic 130 andor diastolic 85 mmHg
5 Elevated fasting glucose 100 mgdL
Percentage of glucose intolerance and metabolic syndrome in PCOS women as well was any differences in parameters between PCOS patients with and without glucose intolerance and metabolic syndrome will be analysed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None